What did @therestoreclinic actually say?
The creator answered a viewer question about whether HCG needs to be cycled during TRT. Their answer: no cycling required. HCG "can be taken indefinitely while on your TRT protocol." They also flagged that a "small subset" of patients become "refractory" to HCG over time, and that those patients may need higher doses, adjusted schedules, or added FSH. The claim is based on clinical observation across "over 2,000 TRT patients."
This is a practical, experience-based answer to a genuinely common question. The creator isn't overclaiming a cure or making wild mechanistic assertions. They're describing a clinical approach and honestly noting its limitations. That's a reasonable starting point, but anecdotal volume isn't the same as evidence, and a few of the details here warrant closer examination.
Does the science back this up?
Mostly, yes, with important caveats. HCG is a luteinizing hormone (LH) analog that stimulates Leydig cells in the testes to produce testosterone and maintain intratesticular testosterone (ITT), which is essential for spermatogenesis. On exogenous testosterone, the pituitary stops releasing LH, so Leydig cells go quiet. HCG keeps them active. The rationale for long-term use is sound.
Studies support continuous HCG use during TRT for men who want to preserve testicular function or fertility. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that low-dose HCG co-administered with exogenous testosterone maintained ITT and spermatogenesis in healthy men. Later work by Hsieh et al. (2013, Journal of Urology) confirmed that HCG can preserve fertility parameters during TRT. Neither study examined indefinite use specifically, but the biology supports it.
The "refractory" phenomenon the creator mentions is less well-documented in controlled trials. There is biological plausibility: prolonged LH-receptor stimulation can cause receptor downregulation, a mechanism studied in the context of ovulation induction and luteal phase defects. But robust clinical data on HCG tachyphylaxis specifically in male TRT patients is thin.
What did they get wrong (or right)?
They got the core claim right. HCG does not need to be cycled in the way anabolic steroid users sometimes cycle it. For men on TRT who want to maintain testicular size, function, or fertility options, continuous low-dose HCG is a legitimate and widely used approach. Credit where it is due.
The "refractory" framing is where things get murkier. The creator says some patients "become somewhat refracted to HCG" and may need more HCG or added FSH. The FSH point is clinically interesting. FSH directly stimulates Sertoli cells, which support sperm development, while HCG works on Leydig cells. For men with persistently low sperm counts despite HCG, adding recombinant FSH (like follitropin) is a recognized clinical strategy. Liu et al. (2009, Journal of Clinical Endocrinology and Metabolism) found that combined gonadotropin therapy improved sperm output in men with secondary hypogonadism.
What the creator does not address is that increasing HCG doses indefinitely carries risks, including estradiol elevation and potential Leydig cell desensitization. Telling patients to simply "increase the amount" without that context is incomplete.
What should you actually know?
If you are on TRT and considering HCG, here is what the evidence actually supports. HCG can be used long-term alongside testosterone to maintain testicular volume and preserve some fertility potential. It is not a fertility guarantee, and it does not fully replace natural gonadotropin signaling in all men. The effective dose range used in clinical practice varies, and higher is not automatically better.
The "refractory" concern the creator raises has biological plausibility but limited controlled data behind it. If you are not responding to HCG as expected, the clinical path forward, whether that means dose adjustment, schedule changes, or adding FSH, should involve a physician evaluating your specific hormone panel and semen analysis, not a generalized protocol.
One thing worth knowing: HCG is currently available in the US primarily through compounded pharmacies for most TRT patients, since the branded version (Pregnyl, Novarel) is often used for other indications and supply has been inconsistent. Compounded HCG is not equivalent to FDA-approved formulations in terms of regulatory oversight. That distinction matters when evaluating any long-term protocol.
- HCG preserves intratesticular testosterone during TRT, which matters for fertility and testicular health.
- Long-term use is supported by the underlying biology and by studies like Coviello et al. (2005).
- True HCG resistance in male TRT patients is clinically observed but not well-studied in randomized trials.
- Adding FSH for men who do not respond adequately to HCG alone is a legitimate, evidence-supported escalation strategy.